Free Trial
NASDAQ:ONVO

Organovo (ONVO) Stock Price, News & Analysis

Organovo logo

About Organovo Stock (NASDAQ:ONVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.66
$15.24
52-Week Range
N/A
Volume
243,634 shs
Average Volume
617,505 shs
Market Capitalization
$3.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

Organovo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

ONVO MarketRank™: 

Organovo scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Organovo.

  • Earnings Growth

    Earnings for Organovo are expected to grow in the coming year, from ($0.77) to ($0.75) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Organovo is -2.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Organovo is -2.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Organovo's valuation and earnings.
  • Percentage of Shares Shorted

    4.32% of the float of Organovo has been sold short.
  • Short Interest Ratio / Days to Cover

    Organovo has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Organovo has recently increased by 30.60%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Organovo does not currently pay a dividend.

  • Dividend Growth

    Organovo does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.32% of the float of Organovo has been sold short.
  • Short Interest Ratio / Days to Cover

    Organovo has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Organovo has recently increased by 30.60%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    2 people have searched for ONVO on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Organovo insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.72% of the stock of Organovo is held by insiders.

  • Percentage Held by Institutions

    Only 8.23% of the stock of Organovo is held by institutions.

  • Read more about Organovo's insider trading history.
Receive ONVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organovo and its competitors with MarketBeat's FREE daily newsletter.

ONVO Stock News Headlines

Two new option listings and one option delisting on April 24th
The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
VivoSim to Carry Forward Organovo 3D Bioprinting
See More Headlines

ONVO Stock Analysis - Frequently Asked Questions

Organovo Holdings, Inc. (NASDAQ:ONVO) released its quarterly earnings results on Wednesday, February, 19th. The medical research company reported ($2.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.52) by $0.24. The medical research company earned $0.02 million during the quarter, compared to the consensus estimate of $0.05 million. Organovo had a negative trailing twelve-month return on equity of 346.26% and a negative net margin of 10,151.64%.

Organovo shares reverse split on the morning of Friday, March 21st 2025. The 1-12 reverse split was announced on Wednesday, March 19th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 20th 2025. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of ONVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organovo investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Brainstorm Cell Therapeutics (BCLI), AST SpaceMobile (ASTS) and Virgin Galactic (SPCE).

Company Calendar

Last Earnings
2/19/2025
Today
5/03/2025
Next Earnings (Estimated)
5/30/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONVO
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,670,000.00
Net Margins
-10,151.64%
Pretax Margin
-10,150.00%

Debt

Sales & Book Value

Annual Sales
$122,000.00
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
N/A

Miscellaneous

Free Float
14,794,000
Market Cap
$3.47 million
Optionable
Optionable
Beta
1.13

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:ONVO) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners